1-(2-Bromo-6-(trifluoromethyl)phenyl)-N,N-dimethylpiperidin-4-amine

Catalog No.: 
ACNWIW137
CAS No.: 
1713160-28-1
Molecular Formula: 
C14H18BrF3N2
Molecular Weight: 
351.21
1-(2-Bromo-6-(trifluoromethyl)phenyl)-N,N-dimethylpiperidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$211.00InquiryInquiry
1g97%$634.00InquiryInquiry
5g97%$3138.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2-Bromo-6-(trifluoromethyl)phenyl)-N,N-dimethylpiperidin-4-amine
IUPAC Name1-(2-bromo-6-(trifluoromethyl)phenyl)-N,N-dimethylpiperidin-4-amine
MDL No.MFCD28013740
Molecular FormulaC14H18BrF3N2
Molecular Weight351.21
SMILESCN(C)C1CCN(C2=C(C(F)(F)F)C=CC=C2Br)CC1
InChI KeyPDBUGXLUQMPJBY-UHFFFAOYSA-N
Synonym1-(2-Bromo-6-(trifluoromethyl)phenyl)-N,N-dimethylpiperidin-4-amine;4-Piperidinamine, 1-[2-bromo-6-(trifluoromethyl)phenyl]-N,N-dimethyl-
CAS No.1713160-28-1

Synthetic Route by SureRoute

1. ACNWIW137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCZK812 route compound structure diagram
    ACBCZK8124876-59-9In Stock
  2. Plus
  3. ACQVKC718 route compound structure diagram
    ACQVKC718144584-67-8In Stock
  4. Then
  5. ACNWIW137 route product structure diagram
    ACNWIW1371713160-28-1
Inquiry

2. ACNWIW137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNWIW137 route product structure diagram
    ACNWIW1371713160-28-1
Inquiry

3. ACNWIW137 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNWIW137 route product structure diagram
    ACNWIW1371713160-28-1
Inquiry

Comments (0)